Barchart on MSN

Why This Top 100 Stock to Buy Is Getting Cheaper Even as It Soars Higher

For my penultimate Barchart article in 2025, I wanted to revisit Indivior (INDV), a Virginia-based developer of opioid ...

This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table

NASDAQ:ADMA: $10.83 million (8.81% of AUM) NASDAQ:EOLS: $9.43 million (7.67% of AUM) NASDAQ:ZVRA: $7.70 million (6.26% of AUM) NASDAQ:NKTR: $4.84 million (3.93% of AUM) As of Friday, Indivior shares ...
Scientific American

U.S. Approves Wegovy Weight-Loss Pill, a Move That Could Transform Health Care

Weight-loss pills that harness the same mechanism as the wildly popular drugs Wegovy and Ozempic are coming to the U.S. On Monday Novo Nordisk announced that the U.S. Food and Drug Administration ...
TechCrunch

OpenAI says AI browsers may always be vulnerable to prompt injection attacks

Even as OpenAI works to harden its Atlas AI browser against cyberattacks, the company admits that prompt injections, a type of attack that manipulates AI agents to follow malicious instructions often ...
Medical Xpress

Eczema injectable drug provides quick itch relief, clinical trial results show

A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new study says. Nemolizumab (Nemluvio) relieved itchiness within two days for three ...
Psychology Today

Sublocade: Directionally Positive But Not a Panacea

The Food & Drug Administration (FDA) announced its approval of an injectable form of buprenorphine (brand name: Sublocade), a medication used to treat opiate addiction. Sublocade releases a steady ...
FierceBiotech

Lilly's obesity pill largely maintains weight lost on injectable GLP-1s

Eli Lilly has shown patients maintained most of their weight loss after switching from injectable GLP-1s to its oral drug candidate, teeing the drugmaker up to target people taking Novo Nordisk’s ...